A61K 39/0013
Therapeutic immunisation against small organic molecules
Official title: {Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine}
A61K39/0013 (Therapeutic immunisation against small organic molecules) appears on 88 US grants and 179 published applications in this corpus.
Search patents in A61K- Granted patents
- 88
- Published applications
- 179
- Assignees
- 93
- Inventors
- 294
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 3 |
| 2003 | 2 | 3 |
| 2004 | 2 | 2 |
| 2005 | 1 | 6 |
| 2006 | 2 | 11 |
| 2007 | 2 | 3 |
| 2008 | 1 | 5 |
| 2009 | 1 | 2 |
| 2010 | 2 | 8 |
| 2011 | 3 | 15 |
| 2012 | 2 | 7 |
| 2013 | 1 | 8 |
| 2014 | 5 | 7 |
| 2015 | 3 | 11 |
| 2016 | 5 | 10 |
| 2017 | 6 | 8 |
| 2018 | 12 | 9 |
| 2019 | 4 | 5 |
| 2020 | 3 | 9 |
| 2021 | 4 | 8 |
| 2022 | 5 | 9 |
| 2023 | 6 | 13 |
| 2024 | 1 | 7 |
| 2025 | 3 | 7 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pregabalin immunoassays16 Jun 2026US 12,656,356 B2ARK Diagnostics, Inc.
- mRNA construct for protein expression and use of same26 May 2026US 12,637,689 B2Korea Research Institute of Bioscience and Biotechnology
- Antibodies against fentanyl and fentanyl analogs18 Nov 2025US 12,472,248 B2The Government of the United States, as represented by the Secretary of the Army
- Molecules that stimulate the immune system for treatment of drug addiction, methods of synthesis, antidrug vaccine and uses6 May 2025US 12,291,527 B2Fundacao De Amparo A Pesquisa Do Estado De Minas Gerais-Fapemig
- Vsg-based vaccination and antibody generation platform for the treatment of diseases29 Apr 2025US 12,285,474 B2Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Method of vaccinating for cancer and device and kit therefor17 Sep 2026US 2026/0273046 A1Purdue Research Foundation
- Compositions and Methods for Treating Fentanyl Dependence20 Aug 2026US 2026/0240972 A1
- Opioid haptens, conjugates, vaccines, and methods of generating antibodies19 Feb 2026US 2026/0049057 A1The Scripps Research Institute
- Anti-fentanyl antibodies25 Dec 2025US 2025/0388701 A1
- Btnl3 proteins, nucleic acids and antibodies and uses thereof27 Nov 2025US 2025/0361283 A1Amgen Inc.
Most cited
By later US patents
- Hapten-carrier conjugates and uses thereof75US 6,932,971 B2Cytos Biotechnology AG · 2005
- Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same54US 5,876,727 AImmuLogic Pharmaceutical Corporation · 1999
- Hapten-carrier conjugates for treating and preventing nicotine addiction42US 6,232,082 B1Nabi · 2001
- Vaccine and immunserum against drugs of abuse41US 6,699,474 B12004
- Immunonanotherapeutics that provide IgG humoral response without T-cell antigen39US 8,277,812 B2Massachusetts Institute of Technology · 2012